Surgical castration of piglets to prevent boar taint in pork is one of the most contested welfare practices in pig farming. Immunocastration and genetic approaches offer alternatives with different welfare profiles.
Piglet castration welfare illustrates the complexity of managing welfare within existing market structures. Boar taint is a genuine consumer quality issue in some markets; surgical castration without pain relief causes genuine welfare harm; and the alternatives each have different welfare and commercial profiles. Immunocastration avoids surgical pain but requires additional handling for injection. Sorting technology avoids castration entirely by detecting taint post-slaughter. The welfare direction is clear - away from surgical castration without analgesia - but the path depends on market acceptance of alternatives and commercial investment in detection technology. Producer welfare certification schemes can drive this transition by specifying minimum pain management standards.